CLL/SLL in 2020
Learning Objectives
- Understand treatment parameters for CLL/SLL
- Understand similarities/differences between MBL/CLL/SLL
- Understand high risk vs low risk CLL/SLL and associated best treatments based on these findings
- Emphasize the importance of testing for IGHV status and clinical implications
- Understand common treatment options with focus on shifting away from CIT for many patients given success of novel therapies (oral agents and immunotherapies)
Available Credit
- 1.00 ACPE - Pharmacist
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 ANCC
- 1.00 Attendance